BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2025 5:57:38 AM | Browse: 84 | Download: 350
 |
Received |
|
2025-03-24 09:33 |
|
Peer-Review Started |
|
2025-03-24 09:33 |
|
First Decision by Editorial Office Director |
|
2025-04-01 05:55 |
|
Return for Revision |
|
2025-04-01 05:55 |
|
Revised |
|
2025-04-13 13:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-05-21 02:51 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-21 14:43 |
|
Articles in Press |
|
2025-05-21 14:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-07 15:23 |
|
Publish the Manuscript Online |
|
2025-11-19 05:57 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Retrospective Study |
| Article Title |
Serum factor V and arterial lactate levels predict graft survival in liver transplant recipients with aminotransferase above five thousand
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gabriel Lazzarotto-da-Silva, Bruno Marches Chaves, Flávia Heinz Feier, Pablo Duarte Rodrigues, Tomaz Jesus Maria Grezzana-Filho, Alexandre de Araujo, Mario Reis Alvares-da-Silva, Roberta Cabral Marchiori, Marcio Fernandes Chedid and Cleber Rosito Pinto Kruel |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Financiamento e Incentivo à Pesquisa of Hospital de Clínicas de Porto Alegre |
No. 170271 |
|
| Corresponding Author |
Marcio Fernandes Chedid, MD, PhD, Professor, Liver Transplant and Hepatobiliary Surgery Unit, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Porto Alegre 90035-007, Rio Grande do Sul, Brazil. mchedid@hcpa.edu.br |
| Key Words |
Aminotransferase; Liver transplantation; Early allograft failure; Factor V; Lactate |
| Core Tip |
Among 341 liver transplant recipients, 25 had an aminotransferase level > 5000 U/L. Early allograft failure (death or re-transplantation within 90 days) occurred in 11 patients. One-year and five-year graft survival rates were 51.7% and 42.6%, respectively. However, approximately 50% of these patients withstood initial graft injury and had a satisfactory long-term prognosis. Therefore, early identification of patients who will recover graft function or undergo graft loss is paramount. Serum factor V and arterial lactate levels can aid in deciding whether to relist patients to retransplantation early in the postoperative period. |
| Publish Date |
2025-11-19 05:57 |
| Citation |
Lazzarotto-da-Silva G, Chaves BM, Feier FH, Rodrigues PD, Grezzana-Filho TJM, de Araujo A, Alvares-da-Silva MR, Marchiori RC, Chedid MF, Kruel CRP. Serum factor V and arterial lactate levels predict graft survival in liver transplant recipients with aminotransferase above five thousand. World J Transplant 2025; 15(4): 107461 |
| URL |
https://www.wjgnet.com/2220-3230/full/v15/i4/107461.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v15.i4.107461 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
